{"nct_id":"NCT02753413","title":"Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women","status":"COMPLETED","status_verified_date":"2018-05","start_date":"2016-04-01","start_date_type":null,"primary_completion_date":"2016-06-28","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}